s6y
Company name or ticker
Search
SYNAGEVA BIOPHARMA CORP
4
Quinn Anthony: Statement of changes in beneficial ownership of securities
Filed
Thursday, April 3, 2014
Period
Apr 1, 2014
Accession number
0001246360-14-002041
Documents
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header